Skip to main content

Publications

2025

Epidemiological and clinical data from the European Lipodystrophy Registry

Ceccarini G, Vatier C, Akinci B, Belalem I, Broekema M, Csajbok E, Rosaria D'Apice M, Gambineri A, Heldt K, Heni M, Kleinendorst L, Krause K, Lattanzi G, Miehle K, Palladino L, Prodam F, Santini F, Santos Silva E, Savage DB, Sbraccia P, Scherer T, Sorkina E, Štotl I, Vantyghem MC, Vigouroux C, Vorona E, Araújo-Vilar D, Wabitsch M, Nagel G, von Schnurbein J; ECLip Registry Consortium

Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms. Neurotherapeutics.

Lage L, Rodriguez-Perez AI, Labandeira-Garcia JL, Dominguez-Meijide A

High-throughput screen identifies MAS9 as a novel inhibitor of the C-type lectin receptor-2 (CLEC-2)-podoplanin interaction

Sowa MA, Wu Y, van Groningen J, Di Y, van den Hurk H, Eble JA, Gibbins JM, García Á, Pollitt AY

IL-6 decodes sex and diet-dependent circadian and metabolic rhythms

González-Vila A, Ibrahim-Alasoufi AM, Luengo-Mateos M, Pardo-García V, Díaz-López A, Fernández-Rodríguez B, Poutanen M, Ohlsson C, Tena-Sempere M, Diéguez-González C, García-García MC, Barca-Mayo O

Mini-GRID therapy delivers optimisedspatially fractionated radiation therapyusing a flattening free filter accelerator

M. Isabel Acuña, Charlotte Lamirault, Thibaut Larcher, Elise Brisebard, Tim Schneider, Marjorie Juchaux, Ramon Iglesias-Rey, Sabela Fernández-Rodicio, Pablo Aguiar, Noemi Gómez-Lado, Immaculada Martínez-Rovira, Roberto González-Vegas, Ibraheem Yousef, Antonio Gomez-Caamano, Miguel Pombar, Victor Luna, Manuel Sanchez & Yolanda Prezado